Literature DB >> 14523186

Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial.

Britta M Svoren1, Deborah Butler, Bat-Sheva Levine, Barbara J Anderson, Lori M B Laffel.   

Abstract

OBJECTIVE: Both acute and chronic complications of diabetes account for a disproportionate percentage of US health care expenditures. Despite improvements in diabetes care, the incidence of adverse events in children with type 1 diabetes remains high, particularly for youths with poor glycemic control. Cost-effective intervention programs designed to reduce complications are needed. This study evaluated a low-intensity, nonmedical intervention using a case manager (called a "Care Ambassador"), with and without the supplementation of psychoeducational modules, designed to monitor and encourage routine diabetes care visits to reduce short-term adverse outcomes and improve glycemic control in youths with type 1 diabetes.
METHODS: We performed a 2-year prospective, randomized clinical trial in 299 youths with type 1 diabetes, aged 7 to 16 years, comparing 3 treatment programs (Care Ambassador [CA], Care Ambassador plus psychoeducational modules [CA+], and standard multidisciplinary diabetes care [SC]). The study was conducted in a large metropolitan US city from April 1997 through April 2000. Number of medical visits, frequency of hypoglycemic events, hospital/emergency department (ED) utilization, and glycosylated hemoglobin A1c were assessed during follow-up.
RESULTS: During the 2-year study period, both the CA and CA+ groups had significantly more routine visits (mean [standard deviation]: 7.3 [2.06] and 7.5 [2.02], respectively) compared with the SC group (5.4 [2.62]). The CA+ intervention group had significantly reduced rates of short-term adverse outcomes compared with the other 2 groups; 25% fewer total hypoglycemic events, 60% fewer severe hypoglycemic events, and 40% fewer hospitalizations and ED visits. "High-risk" youths in the CA+ group (baseline glycosylated hemoglobin A1c > or =8.7%) were 3.4-fold (1.57-7.41) more likely to improve their glycemic control compared with those at high risk in the other 2 groups.
CONCLUSIONS: For youths with type 1 diabetes, the CA and CA+ interventions increased visit frequency. Youths in the CA+ intervention had reduced rates of hypoglycemia and hospital/ED utilization with estimated annual cost savings of 80 000 dollars to 90 000 dollars. The CA+ intervention compared with the other 2 groups improved glycemic control in "high-risk" youths. Nonmedical case management incorporating psychoeducational modules seems to be a cost-effective approach to improving outcomes in youths with diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523186     DOI: 10.1542/peds.112.4.914

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

1.  A pilot study of acute stress symptoms in parents and youth following diagnosis of type I diabetes.

Authors:  Ginger Depp Cline; David D Schwartz; Marni E Axelrad; Barbara Anderson
Journal:  J Clin Psychol Med Settings       Date:  2011-12

Review 2.  Getting (the most) out of the research business: interventions for youth with T1DM.

Authors:  Michael A Harris; Kurt A Freeman; Danny C Duke
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

3.  Multisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trial.

Authors:  Deborah A Ellis; Sylvie Naar-King; Xinguang Chen; Kathleen Moltz; Phillippe B Cunningham; April Idalski-Carcone
Journal:  Ann Behav Med       Date:  2012-10

Review 4.  New developments in the treatment of type 1 diabetes in children.

Authors:  Thomas Danne; Karin Lange; Olga Kordonouri
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

5.  Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Authors:  G H Teló; C E Dougher; L K Volkening; M L Katz; L M Laffel
Journal:  Diabet Med       Date:  2018-06-19       Impact factor: 4.359

6.  Characteristics of adolescents with type 1 diabetes who exhibit adverse outcomes.

Authors:  Carla Johns; Melissa Spezia Faulkner; Lauretta Quinn
Journal:  Diabetes Educ       Date:  2008 Sep-Oct       Impact factor: 2.140

7.  Reduction of hypoglycaemic events with a behavioural intervention: a randomized clinical trial for paediatric patients with Type 1 diabetes mellitus.

Authors:  B T Gee; T R Nansel; A Liu
Journal:  Diabet Med       Date:  2016-11-24       Impact factor: 4.359

8.  Evidence-based behavioral interventions to promote diabetes management in children, adolescents, and families.

Authors:  Marisa E Hilliard; Priscilla W Powell; Barbara J Anderson
Journal:  Am Psychol       Date:  2016-10

9.  Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial.

Authors:  Emina Obarcanin; Manfred Krüger; Petra Müller; Verena Nemitz; Holger Schwender; Snijezana Hasanbegovic; Sena Kalajdzisalihovic; Stephanie Läer
Journal:  Int J Clin Pharm       Date:  2015-04-28

10.  Maximising engagement, motivation and long term change in a Structured Intensive Education Programme in Diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE).

Authors:  Deborah Christie; Vicki Strange; Elizabeth Allen; Sandy Oliver; Ian Chi Kei Wong; Felicity Smith; John Cairns; Rebecca Thompson; Peter Hindmarsh; Simon O'Neill; Christina Bull; Russell Viner; Diana Elbourne
Journal:  BMC Pediatr       Date:  2009-09-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.